Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-27

Clinical Trial Update: Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.

View source ↗

Summary

A clinical trial assessing electroencephalographic profiles in neuropathic pain patients treated with intravenous ketamine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neuropathic Pain | Status: WITHDRAWN